This study examines in a prospective, multicenter trial the feasibilit
y and advantage of current-based, transthoracic defibrillation. Curren
t-based, damped, sinusoidal waveform shocks of 18, 25, 30, 35, or 40 a
mperes (A) were administered beginning with 25 A for polymorphic ventr
icular tachycardia (VT) and ventricular fibrillation (VF) or 18 A for
monomorphic VT; success rates were compared with those of energy-based
shocks beginning at 200 J for VF/polymorphic VT and 100 J for VT. The
current-based shocks were delivered from custom-modified defibrillato
rs that determined impedance in advance of any shock using a ''test-pu
lse'' technique; the capacitor then charged to the exact energy necess
ary to deliver the operator-selected current against the impedance det
ermined by the defibrillator. Three hundred sixty-two patients receive
d >1 shock for VF, polymorphic VT, or monomorphic VT: 569 current- bas
ed shocks and 420 energy-based shocks. Current-based shocks of 35/40 A
achieved success rates of up to 74% for VF/polymorphic VT; 30 A shock
s terminated 88% of monomorphic VT episodes. Energy-based shocks of 30
0 J terminated 72% of VF/polymorphic VT; 200-J shocks terminated 89% o
f monomorphic VT. We could not demonstrate a significant increase in t
he success rate of current-based shocks over energy-based shocks for p
atients with high transthoracic impedance; this may be due to inadequa
te sample size. Thus, current-based defibrillation is clinically feasi
ble and effective. A larger study will be needed to test whether curre
nt-based defibrillation is superior to energy-based defibrillation. (C
) 1996 by Excerpta Medica, Inc.